Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Structural Analysis of Ex Vivo Amyloid Fibrils From AL Amyloidosis
by
Radamaker, Lynn
in
Alzheimer's disease
/ Amino acids
/ Amyloidosis
/ Antibodies
/ Antigens
/ Biomarkers
/ Chemical bonds
/ Crystallography
/ Disease
/ Genes
/ Glycosylation
/ Heart
/ Immunoglobulins
/ Immunology
/ Medical research
/ Medicine
/ Mutation
/ Nervous system
/ Parkinson's disease
/ Patients
/ Physiology
/ Plasma
/ Polymorphism
/ Polypeptides
/ Software
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structural Analysis of Ex Vivo Amyloid Fibrils From AL Amyloidosis
by
Radamaker, Lynn
in
Alzheimer's disease
/ Amino acids
/ Amyloidosis
/ Antibodies
/ Antigens
/ Biomarkers
/ Chemical bonds
/ Crystallography
/ Disease
/ Genes
/ Glycosylation
/ Heart
/ Immunoglobulins
/ Immunology
/ Medical research
/ Medicine
/ Mutation
/ Nervous system
/ Parkinson's disease
/ Patients
/ Physiology
/ Plasma
/ Polymorphism
/ Polypeptides
/ Software
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Structural Analysis of Ex Vivo Amyloid Fibrils From AL Amyloidosis
by
Radamaker, Lynn
in
Alzheimer's disease
/ Amino acids
/ Amyloidosis
/ Antibodies
/ Antigens
/ Biomarkers
/ Chemical bonds
/ Crystallography
/ Disease
/ Genes
/ Glycosylation
/ Heart
/ Immunoglobulins
/ Immunology
/ Medical research
/ Medicine
/ Mutation
/ Nervous system
/ Parkinson's disease
/ Patients
/ Physiology
/ Plasma
/ Polymorphism
/ Polypeptides
/ Software
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Structural Analysis of Ex Vivo Amyloid Fibrils From AL Amyloidosis
Dissertation
Structural Analysis of Ex Vivo Amyloid Fibrils From AL Amyloidosis
2021
Request Book From Autostore
and Choose the Collection Method
Overview
The disease AL amyloidosis is caused by the misfolding of immunoglobulin light chains (LC). Due to an underlying plasma cell dyscrasia, amyloidogenic LCs are overproduced and their high serum concentrations lead to aggregation and amyloid fibril formation. The ensuing organ damage can be fatal, in particular in case of cardiac involvement. Current treatment options target the plasma cell clone, thereby reducing LC production and amyloid formation. However, no amyloid-targeting therapies are available and high-risk patients with advanced cardiac damage often die within months of diagnosis as the available treatments are unable to rapidly restore organ function. Being a patient-specific disease, the molecular mechanisms determining pathogenesis in AL amyloidosis are poorly understood. In particular, it is unclear how different factors influence amyloid fibril formation by the pathogenic LCs.AL amyloidosis is a member of the group of clinical disorders termed the amyloidoses, which are based on the misfolding of different proteins into amyloid fibrils. Amyloid fibrils formed in vivo or in vitro from different proteins show similar characteristics: a long and straight appearance under an electron microscope, binding to amyloid-specific dyes, as well as a cross-β X-ray diffraction pattern. Although in vitro formed fibrils are generally easier to study than fibrils that are directly extracted from amyloidotic tissue, it remains to be established whether in vitro fibril structures are relevant to disease. Therefore, in order to shed light on disease processes, it is important to study ex vivo fibrils.LCs are highly variable proteins due their natural function as antibody constituents. The LC sequence variability is a result of genetic recombination, junctional diversity and somatic hypermutation. These processes take place during the production and maturation of B cells. Previous studies have shown that AL fibril proteins contain several post-translational modifications (PTMs). AL fibril proteins have generally been proteolyzed and contain a disulfide bond. Also, AL LCs are more often glycosylated than non-amyloidogenic LCs and sometimes pyroglutamylated. The contributions of sequence variability and PTMs to the structure and stability of AL amyloid fibrils are unclear. Structural information on AL amyloid fibrils is required to elucidate the influence of these factors. Previous studies have investigated the three-dimensional (3D) structure of AL amyloid fibrils using X-ray crystallography, solid-state nuclear magnetic resonance (ssNMR), negative-stain electron microscopy and cryo-electron microscopy (cryo-EM). However, these models were based on (short) fragments of LCs that were fibrillated in vitro and it is unclear whether they correspond to pathogenic, in vivo formed amyloid fibril structures.In this thesis, 3D structures of pathogenic AL fibrils from three patient cases were obtained using cryo-EM. By imaging the AL fibrils directly in vitreous ice, their structures could be obtained by 3D reconstruction and molecular modeling. The models revealed that a rotational switch around the LC disulfide bond takes place during misfolding. Two similar amyloid folds, differing only in a short segment of the polypeptide chain, were found to occur within a single amyloid fibril, forming structural breaks at their interface. These structural breaks could play a role in, e.g., fibril fragmentation or interactions with other molecules. Furthermore, the structure of a glycosylated AL fibril showed that the glycosylation is present on the surface of the fibril where it protects the fibril from proteolytic degradation. By comparing the available ex vivo AL fibril structures, it was shown that mutations enable the LC fragments to adopt a proteolytically stable morphology that is able to withstand the degradation mechanisms in the body. The same LC fragments may adopt different amyloid folds in vitro, as demonstrated by an ssNMR study. In conclusion, this thesis has expanded the understanding of the molecular basis of AL amyloidosis by elucidating the influence of mutations and PTMs on the structure and stability of AL fibrils, as well as on the misfolding process. These insights could aid in the development of novel diagnostic tools and therapeutic approaches.
This website uses cookies to ensure you get the best experience on our website.